Is hsCRP useful for blood sugar?

Is hsCRP useful for blood sugar? The short answer is: indirectly, yes, but with important caveats. High-sensitivity C-reactive protein (hsCRP) is a marker of systemic inflammation, and chronic low-grade inflammation is a key driver of insulin resistance and impaired glucose metabolism. Epidemiological studies consistently show that elevated hsCRP predicts future type 2 diabetes risk, independent of traditional risk factors. However, hsCRP does not measure blood glucose directly; it reflects inflammatory activity that can contribute to metabolic dysregulation. Its clinical utility lies in risk stratification: a high hsCRP should prompt further metabolic workup (fasting glucose, HbA1c, oral glucose tolerance test). Interpretation is confounded by acute illness, smoking, medications, and supplements (e.g., sumac, which a 2025 meta-analysis [PMID:41372916] found lowers hsCRP). Therefore, hsCRP alone is insufficient for diagnosing or monitoring blood sugar disorders. The evidence for the hsCRP–diabetes link is moderate (prospective cohort studies, not randomized trials). In practice, hsCRP is best used as part of a comprehensive cardiovascular and metabolic risk assessment, not as a standalone blood sugar test. A normal hsCRP does not rule out prediabetes or diabetes. Bottom line: useful as a complementary risk marker, but not a substitute for direct glycemic measures.